Viewing Study NCT02423057


Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-01-22 @ 8:58 PM
Study NCT ID: NCT02423057
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2015-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module